Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

dimethyl

dimethyl is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 8
News articles 0
Drug details — dimethyl
Class
—
Route
—
Patents
20
Programs
8
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

dimethyl is an FDA-listed pharmaceutical active ingredient.

Key facts

INN dimethyl

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. COMB157G3301 Phase 3 · Novartis India · relapsing multiple sclerosis (RMS)
  2. dimethyl fumarate Phase 3 · Biogen · Relapsing-Remitting Multiple Sclerosis
  3. DIMETHYL FUMARATE, DIMETHYL FUMARATE Phase 2 · PARItec · Macular degeneration
  4. Dimethyl fumarate Phase 2 · Xuanwu Hospital · Intracerebral Hemorrhage
  5. MATRIx Phase 2 · Telethon Foundation · Traumatic Brain Injury
  6. CPDR001X2X01B Phase 1 · Novartis India · Different types of advanced cancer
  7. NXPTEGO/23/P1-4 Phase 1 · NEURAXPHARM AUSTRALIA PTY · Multiple Sclerosis
  8. Dimethyl fumarate Approved · Biogen · Multiple Sclerosis

Related patents

Browse patents

  1. EP 4691463

    VERFAHREN ZUR PRÄVENTION ODER BEHANDLUNG VON HERZVERSAGEN BEI EINEM PATIENTEN MIT (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXAMID

    Expires Tue Feb 06 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12344596

    Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11291662

    Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11148998

    Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10537565

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10351587

    Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

    Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10011562

    Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9931334

    Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9670163

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9586925

    1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9139530

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9045425

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8933071

    Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8785476

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8754224

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8674108

    Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8471029

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8410274

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8372979

    Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8362253

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is dimethyl?

dimethyl is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.